Pierre Fabre
Trending Articles
Related Content
Media
Cellectar Biosciences and Pierre Fabre collaborate to develop drug conjugates
Cellectar Biosciences, an oncology-focused, clinical stage biotechnology company, together with French pharmaceutical company Pierre Fabre, will extend its ongoing collaboration to develop new phospholipid drug conjugates (PDCs)
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.